Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

NCT06055439

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +17 more
Locations
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • Scottsdale Medical Imaging, LLC Scottsdale, Arizona, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Methodist Medical Center of Illinois Peoria, Illinois, United States
View all 51 locations
View Trial Details
Recruiting

Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

NCT07272512

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Huadong Hospital Affiliated to Fudan University Shanghai, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, China
  • Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine Shanghai, China
  • Shanghai General Hospital shanghai jiao tong university school of medicine Shanghai, China
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions